Secondly, our manuscript revealed that SGLT-2i produces a marked cardioprotective effect through the TLR4/NF-κB pathway in diabetic animal model and SGLT-2i could suppress atrial structural remodeling and electrical remodeling and reduce the incidence of AF in diabetic rats. Here, NFKB1 is linked to atrial fibrillation.